SCHEMBL4464100

SCHEMBL4464100

CCc1nc(CN2CCN(c3nccc4[nH]c(-c5ccc(C(C)(C)C)cc5)nc34)CC2)c(C)[nH]1

nearest known ligand 0.75

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GNRHR P30968 18/20 0.75
KDM4E B2RXH2 1/20 0.53
CYP2D6 P10635 1/20 0.53
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4461348 0.86 GNRHR (0.75) GNRHRKDM4ECYP2D6KMT2A
SCHEMBL4468013 0.83 GNRHR (1.00) GNRHR
SCHEMBL4460786 0.79 GNRHR (0.75) GNRHR
SCHEMBL4471830 0.78 GNRHR (0.78) GNRHR
SCHEMBL4482355 0.77 GNRHR (0.56) GNRHR
SCHEMBL4463451 0.76 GNRHR (0.75) GNRHR
SCHEMBL4461442 0.76 GNRHR (0.75) GNRHR
SCHEMBL4465228 0.76 GNRHR (0.77) GNRHR
SCHEMBL3278542 0.75 GNRHR (0.78) GNRHR
SCHEMBL3278482 0.75 GNRHR (0.76) GNRHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538113-B2 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-26 US claimed
US-20060189618-A1 4-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2006-08-24 US claimed
US-7538113-B2 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-05-26 US disclosed
US-20060189618-A1 4-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189618-A1 4-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor GNRHR, LHCGR, FSHR GNRHR 1/4885KDM4E 657/4885CYP2D6 2877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.